TipRanks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market
VRCA
Verrica Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRCA full AI Analyst Report?

Verrica Pharmaceuticals (VRCA) Stock News & Sentiment

492 Followers
Verrica Pharmaceuticals Earnings Call: Growth Amid Losses
Premium
Company Announcements
Verrica Pharmaceuticals Earnings Call: Growth Amid Losses
2M ago
VRCA
Verrica: Buy Rating Reiterated on YCANTH Momentum, Pivotal Wart Program Progress, and Strengthened Balance Sheet; $12 Price Target Maintained
Premium
Ratings
Verrica: Buy Rating Reiterated on YCANTH Momentum, Pivotal Wart Program Progress, and Strengthened Balance Sheet; $12 Price Target Maintained
2M ago
VRCA
Stacy Ku Reiterates Buy on Verrica as Ycanth’s Strong Uptake and Wart Expansion Opportunity Support Long-Term Growth
Premium
Ratings
Stacy Ku Reiterates Buy on Verrica as Ycanth’s Strong Uptake and Wart Expansion Opportunity Support Long-Term Growth
2M ago
VRCA
Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV
Premium
Company Announcements
Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV
4M ago
VEEV
VRCA
Verrica Shareholders Approve Governance Measures at Annual Meeting
Premium
Company Announcements
Verrica Shareholders Approve Governance Measures at Annual Meeting
4M ago
8K
VRCA
Verrica Pharmaceuticals Earnings Call Highlights Growth, Strain
Premium
Company Announcements
Verrica Pharmaceuticals Earnings Call Highlights Growth, Strain
5M ago
VRCA
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
Premium
Ratings
Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating
7M ago
VRCA
More VRCA News >

VRCA News on the Web

Verrica Pharmaceuticals Earnings Call: Growth Amid Losses
TipRanks News
Neutral
Verrica’s Leadership Makes Bold Insider Bet on the Company’s Future
TipRanks News
Neutral
Stacy Ku Reiterates Buy on Verrica as Ycanth’s Strong Uptake and Wart Expansion Opportunity Support Long-Term Growth
TipRanks News
Bullish
Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV
TipRanks News
Bullish
Verrica Shareholders Approve Governance Measures at Annual Meeting
TipRanks News
Neutral
Verrica Pharmaceuticals assumed with a Buy at H.C. Wainwright
TipRanks News
Bullish
Verrica Pharmaceuticals Earnings Call Highlights Growth, Strain
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sionna Therapeutics, Inc. (SION), Verrica Pharmaceuticals (VRCA) and Arvinas Holding Company (ARVN)
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRCA’s Media Buzz Sentiment?
Currently, no data Available
What is VRCA’s weekly average amount of articles?
In an average week, 0.75 articles about VRCA are published.
    What is VRCA’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week